Cancel
Humane Genomics
See Linkedin
Humane Genomics Employees
6 people indexed:
-
kj92tt.@2wtwtxfp96qltz.270 Sign up to see email
-
62pb.fv3t8@05k8zbwf8zxwqz.xj2 Sign up to see email
-
5tbxz.@10y02109r54vf2.54v Sign up to see email
-
75x1f.fl99dbqvk2z2yd@q012yx1824qzbl.l8k Sign up to see email
-
712k0.@tz0xkfjlt90x07.5fy Sign up to see email
-
v27qp0.@p25wf33vfbz3w2.18w Sign up to see email
Humane Genomics Company Information
Humane Genomics, located in New York, NY, USA, operates within the healthcare and therapeutics industry. Founded in 2021 and part of Y Combinator’s S21 batch, the company has a small team of five members. Humane Genomics is pioneering in the field of synthetic biology and hard tech to create oncolytic viral therapies. Their innovative platform leverages the Vesicular Stomatitis Virus (VSV) known for its linear genome and highly lytic nature, which facilitates the engineering of viruses that selectively infect and kill cancer cells while sparing healthy cells. The company’s current focus is on pediatric liver cancer, specifically hepatoblastoma, where their in vivo studies in mice have demonstrated a 50% reduction in tumor volume. They have developed a virus with a ‘2 factor authentication’ system for selective infection and replication, achieving an on-target to off-target kill ratio greater than 1000. Humane Genomics partners with Texas Children’s Hospital and is active in the United States and Canada, aiming to revolutionize cancer treatment through their state-of-the-art platform that ensures safety, efficacy, and cost-effective production.
Report inaccurate information
Report inaccurate information